University of Maryland Greenebaum Comprehensive Cancer Center. NCI-designated comprehensive cancer center. National leader in cancer care and research.
Joined December 2008
- Tweets 1,933
- Following 649
- Followers 8,233
- Likes 346
250 Photos and videos
“I mean, it’s a whole new life.” Jessica Ceja talks about receiving breakthrough gene therapy for sickle cell disease in this @NBCWashington report. nbcwashington.com/news/healt…
2
54
Gene therapy may dramatically change the lives of patients with sickle cell disease. See how UMGCCC is transforming care in the @BaltimoreBanner story featuring UMGCCC & @UMmedschool’s Dr.'s Jean Yared Jennie Law, & their 41-year-old patient Jessica Ceja. thebanner.com/community/publ…
362
Monday at 7 p.m., tune in to @marylandpubtv's Your Health. UMMC gastroenterologist Dr. Ekta Gupta discusses the rise in colorectal cancer among younger adults, what may be driving it, and steps people can take to help reduce their cancer risk.
1
2
230
To watch a livestream of Monday’s program, visit: mpt.org/programs/direct-conn…
129
RT @JeremyLDavisMD: Ready for the #StomachCancer Patient Empowerment Summit hosted by @StoCANcer. Looking forward to a great day! #Gastric…
2
UMGCCC retweeted
Mar 8
WATCH 👀: Ranee Mehra, MD, of @UMGCCC discusses efficacy data for subcutaneous amivantamab plus pembrolizumab in HNSCC from multiple clinical trials.
See the whole video here ➡️: hubs.li/Q045Y7-J0
#hncsm #oncology
1
1
500
UMGCCC retweeted
Great way to close out #SSO2026 with 2 amazing presentations by Dr Rachael Belcher and @AmberFGallanis on #CDH1 research. @MarylandSurg @UMGCCC
8
21
1,354
Rates of colorectal cancer are rising in young people. Hear more from Dr. Ekta Gupta, Chief of Gastroenterology at UMMC's Midtown Campus and Associate Professor of Medicine @UMmedschool, in @wbaltv11's story about risk factors and symptoms to look out for.
wbaltv.com/article/colorecta…
1
490
UMGCCC retweeted
Proud of our speakers at #ACRO2026 & #ACROSEAL 2026, expanding our department’s missions in sharing cutting-edge #radonc research and leadership skills! #RadiatingExcellence Dr. Jason Molitoris @JKMolitoris, Dr. Zak Rana @ZakieRana, Jamie LePage, Kimberly Simmons-Lee & Melissa Albright
2
2
512
UMGCCC retweeted
Mar 6
The PrE0510 #ClinicalTrial, led by @teekayowo of @UMGCCC, aims to determine the optimal dose of ivonescimab in combo with carboplatin & etoposide for patients with #SmallCellLungCancer. More: bit.ly/PrE0510 #LCSM #LungCancer #SCLC
1
1
98
UMGCCC's Dr. Mark V. Mishra (@MarkMishraMD) is senior author of a recently published study that found a sizeable proportion of patients who experience neurocognitive function failure following brain radiation eventually attain full and sustained cognitive recovery.
1
2
4
237
Read the full Journal of the National Cancer Institute publication: pubmed.ncbi.nlm.nih.gov/4112…
#CancerResearch
1
114
UMGCCC retweeted
Dr Yinin Hu - expert in Thyroid Cancer @UMGCCC and alumnus of @MSKCancerCenter is presenting on genomic testing in DTC. #SSO2026 @MarylandSurgery
3
6
854
UMGCCC retweeted
Proud to support the Maryland Half Marathon & 5K on June 6 and the fight against cancer at @UMGCCC. Together, we make an impact. #MarylandHalfMarathon #5K #ThisIsWhyWeRun secure.ummsfoundation.org/si…
1
1
596
UMGCCC retweeted
Mar 2
WATCH: @RaneeMehra, of @UMGCCC, discusses the design of the OrigAMI-5 trial of pembrolizumab plus amivantamab and carboplatin for recurrent or metastatic HNSCC. #hncsm #oncology
onclive.com/view/dr-mehra-on…
1
2
402
UMGCCC retweeted
Mar 2
📹Watch @RaneeMehra, of @UMGCCC, highlight the future of the HNSCC treatment paradigm! See our site for more head and neck cancer insights from Dr Mehra. #hncsm #oncology
onclive.com/video-series/dr-…
1
4
641
UMGCCC retweeted
Mar 3
WATCH: @RaneeMehra, of @UMGCCC, highlights how the ongoing OrigAMI-5 study may address an unmet need for patients with treatment-naive, recurrent or metastatic HNSCC. #hncsm #oncology
onclive.com/view/dr-mehra-on…
2
3
444
UMGCCC retweeted
Feb 27
The PrE0510 #ClinicalTrial, led by @teekayowo of @UMGCCC, aims to determine the optimal dose of ivonescimab in combo with carboplatin & etoposide for patients with #SmallCellLungCancer. More: clinicaltrials.gov/study/NCT… #LCSM #LungCancer #SCLC
1
1
229
UMGCCC retweeted
Feb 27
WATCH: @RaneeMehra, of @UMGCCC, discusses the toxicities associated with subcutaneous amivantamab in recurrent or metastatic HNSCC. #hncsm #Oncology onclive.com/view/dr-mehra-on…
1
2
297
UMGCCC retweeted
Feb 27
WATCH: @RaneeMehra, of @UMGCCC, discusses the efficacy of subcutaneous amivantamab plus pembrolizumab in patients with first-line recurrent or metastatic HNSCC. #hncsm #oncology
onclive.com/view/dr-mehra-on…
1
4
297